Status:
COMPLETED
Key Performance Indicators for the Assessment of NSCLC Patients Pathway
Lead Sponsor:
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Collaborating Sponsors:
Azienda USL Reggio Emilia - IRCCS
Azienda Ospedaliera Universitaria Policlinico
Conditions:
Non Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a multicenter, observational study involving a retrospective collection of data. A total of potential 16 key performance indicators (KPIs) had been developed from a panel of experts (clinician...
Detailed Description
This is a multi-center, observational study involving retrospective collection of NSCLC patients information. All consecutive patients who had a newly diagnosis of NSCLC in 2017 from healthcare admini...
Eligibility Criteria
Inclusion
- \- patients identified from hospital administrative databases of Emilia-Romagna region using a case selection algorithm for identifying Non small cell lung cancer
Exclusion
- patients not residing in Emilia Romagna region (due to the difficulty in obtaining the medical data).
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 15 2020
Estimated Enrollment :
430 Patients enrolled
Trial Details
Trial ID
NCT04676321
Start Date
October 1 2020
End Date
November 15 2020
Last Update
December 21 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
IRST
Meldola, Forlì-Cesena, Italy, 47014
2
IRCCS Arcispedale S.Maria Nuova
Reggio Emilia, RE, Italy, 42123
3
Policlinico of Modena
Modena, Italy, 41125